Abstract
MyoD regulates skeletal muscle differentiation (SMD) and is essential for repair of damaged tissue. The transcription factor nuclear factor kappa B (NF-kappaB) is activated by the cytokine tumor necrosis factor (TNF), a mediator of skeletal muscle wasting in cachexia. Here, the role of NF-kappaB in cytokine-induced muscle degeneration was explored. In differentiating C2C12 myocytes, TNF-induced activation of NF-kappaB inhibited SMD by suppressing MyoD mRNA at the posttranscriptional level. In contrast, in differentiated myotubes, TNF plus interferon-gamma (IFN-gamma) signaling was required for NF-kappaB-dependent down-regulation of MyoD and dysfunction of skeletal myofibers. MyoD mRNA was also down-regulated by TNF and IFN-gamma expression in mouse muscle in vivo. These data elucidate a possible mechanism that may underlie the skeletal muscle decay in cachexia.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
CHO Cells
-
Cachexia / etiology*
-
Cachexia / metabolism
-
Cachexia / pathology
-
Cell Differentiation
-
Cell Line
-
Cricetinae
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism
-
Down-Regulation
-
I-kappa B Proteins*
-
Interferon-gamma / pharmacology
-
Interleukins / pharmacology
-
Mice
-
Mice, Inbred Strains
-
Mice, Nude
-
Muscle, Skeletal / cytology*
-
Muscle, Skeletal / metabolism*
-
Muscle, Skeletal / pathology
-
MyoD Protein / genetics*
-
MyoD Protein / metabolism
-
NF-KappaB Inhibitor alpha
-
NF-kappa B / genetics
-
NF-kappa B / metabolism*
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Transcription Factor RelA
-
Transcription, Genetic
-
Transfection
-
Tumor Necrosis Factor-alpha / pharmacology*
Substances
-
DNA-Binding Proteins
-
I-kappa B Proteins
-
Interleukins
-
MyoD Protein
-
NF-kappa B
-
Nfkbia protein, mouse
-
RNA, Messenger
-
Transcription Factor RelA
-
Tumor Necrosis Factor-alpha
-
NF-KappaB Inhibitor alpha
-
Interferon-gamma